Quetiapine-induced Diabetic Ketoacidosis
- PMID: 29403139
- PMCID: PMC5795688
- DOI: 10.4103/IJPSYM.IJPSYM_125_17
Quetiapine-induced Diabetic Ketoacidosis
Abstract
Psychomotor retardation and extrapyramidal symptoms have limited the conventional antipsychotic use. Atypical antipsychotics though widely prescribed with good tolerability and efficacy, the metabolic complications associated with them are of clinical importance. Diabetic ketoacidosis (DKA) is a fatal complication of atypical antipsychotic use. We report a case of new-onset diabetes presenting as DKA with quetiapine use.
Keywords: Diabetic ketoacidosis; new-onset diabetes mellitus; quetiapine.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Jin H, Meyer JM, Jeste DV. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases. Ann Clin Psychiatry. 2002;14:59–64. - PubMed
-
- Ratnakaran B, Sethulakshmi S. Diabetic ketoacidosis associated with quetiapine treatment: A case report. Kerala J Psychiatry. 2015;28:34–7.
-
- Sobel M, Jaggers ED, Franz MA. New-onset diabetes mellitus associated with the initiation of quetiapine treatment. J Clin Psychiatry. 1999;60:556–7. - PubMed
-
- Muench J, Carey M. Diabetes mellitus associated with atypical antipsychotic medications: New case report and review of the literature. J Am Board Fam Pract. 2001;14:278–82. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources